Cargando…

A clinical study on drug-related problems associated with intravenous drug administration

BACKGROUND: Infusion therapy through intravenous (IV) access is a therapeutic option used in the treatment of many hospitalized patients. IV therapy is complex, potentially dangerous and error prone. The objectives were to ascertain the drug-related problems (DRPs) involved in IV medication administ...

Descripción completa

Detalles Bibliográficos
Autores principales: Vijayakumar, A., Sharon, E. V., Teena, J., Nobil, S., Nazeer, I.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Medknow Publications & Media Pvt Ltd 2014
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4074696/
https://www.ncbi.nlm.nih.gov/pubmed/25031500
http://dx.doi.org/10.4103/0976-0105.134984
Descripción
Sumario:BACKGROUND: Infusion therapy through intravenous (IV) access is a therapeutic option used in the treatment of many hospitalized patients. IV therapy is complex, potentially dangerous and error prone. The objectives were to ascertain the drug-related problems (DRPs) involved in IV medication administration and further to develop strategies to reduce and prevent the occurrence of DRPs during IV administration. MATERIALS AND METHODS: A prospective observational study was carried out for a period of 4 months. Patients receiving more than two medications through IV route were included and studied. RESULTS: Of 110 patients, 76 (69.09%) were male and the rest were female. Nearly, half of the patients (46.3%, n = 51) were reported with DRPs. Of the 80 DRPs (72.72%) documented, 61 problems (55.4%) were seen in patients given IV medications through peripheral line. Among the DRPs majority seen were incompatibilities (40.9%, n = 45), followed by complications developed (12.7%, n = 14), errors in rate of administration (10.9%), and dilution errors (8%). To study the association of DRPs among gender, statistical analysis was performed and significant association was seen between DRPs and gender (P = 0.03). CONCLUSION: Among the reported DRPs, simultaneous IV administration of two incompatible drugs was the main predicament faced.